Welcome to the DarkDaily.com Special Reports Library
Created and maintained as a service to the Clinical and Anatomic Pathology Industry, this unique library program provides laboratory executives with:
- An important and useful resource for knowledge and information about the management of labs
- A one of a kind, in-depth intelligence report on Lab Quality, Lab Management, Collections and Billing and much more
New Special Reports are added frequently, so please check back!
What Hospital and Health Network Labs Must Know to Comply with PAMA Private Payer Price Reporting
This comprehensive workshop is designed to help hospital CEOs, CFOs, their laboratory administrators, and others tasked with data reporting and other requirements of PAMA to fulfill this federal law, with the data reported used to calculate an updated Clinical Laboratory Fee Schedule expected to go into effect Jan. 1, 2021.
“What Hospital and Health Network Clinical Laboratories Must Know to Comply with PAMA Private Payer Price Reporting” is based on federal guidance, enhanced by the expertise of health law practice attorneys, health system leaders who are already reporting data, and other experts. This series of 8 videos comes with a comprehensive companion PDF handbook that supplements the videos, and helps weave together the maze of federal guidance into a wealth of easily accessible resources.
This program package is an ideal educational and training tool for each team member tasked with the PAMA data reporting project, as well as the hospital, health system, and medical laboratory leader who must certify their organization’s data to CMS in a timely manner.
Intelligence Assessment of Today’s Clinical Laboratory Industry
We are at a historic crossroads, both in healthcare and in laboratory medicine. We’re seeing a pace of change and transformation that’s unprecedented since World War II. Successful labs require awareness and a keen understanding of the emerging healthcare marketplace.
Learn how your medical lab can survive the transition from volume- to value-based healthcare, by identifying opportunities to deliver recognized, unquestioned value to physicians, patients, parent hospitals, health systems and payers.
The Growing Role of Quality Management Systems In Clinical Laboratory Accreditation and Licensure
CLIA inspections are growing tougher every year. It’s the same story with Medicare accreditation of clinical laboratories. Requirements are tightening. Onsite lab inspections and assessments are becoming more rigorous.
Get a full understanding of how and why the use of a Quality Management System (QMS) is such a powerful way to put your laboratory at full compliance, ready for surprise inspections that result in a “no deficiency” outcome.
Latest E-Briefings
Federal Government Is Sending Nearly $11 Billion to States for COVID-19 Clinical Laboratory Testing and Testing-Related Activities
Questions remain, however, over how much of the funding will actually reach hospital and health system clinical laboratories For many cash-strapped clinical laboratories in America, the second round of stimulus funds cannot come soon enough. Thus, lab leaders are...
Harvard ‘Roadmap’ to Recovery Calls for ‘Massive’ Increase in Clinical Laboratory COVID-19 Testing in Four-Phase Blueprint for Reopening Economy
Report’s authors claim the US needs to be testing 20-million people per day in order to achieve ‘full pandemic resilience’ by August Medical laboratory scientists and clinical laboratory leaders know that the US’ inability to provide widespread diagnostic testing to...
Health Insurers and Hospital Groups Argue Price Transparency Rules on Hospitals, Clinical Laboratories, and Other Providers Will Add Costs and ‘Confuse’ Consumers
Insurance industry claims new federal price transparency regulations cost each payer as much as $13.6 million in set up and maintenance costs Price transparency in hospital, clinical laboratory, and other service provider costs marches ever closer to reality for...
Roche CEO Severin Schwan Questions the Ethics of Certain Companies Making COVID-19 Antibody Tests and Calls Some of These Clinical Laboratory Tests a ‘Disaster’
Schwan’s concerns about inaccurate or unreliable COVID-19 serology tests were supported when the FDA issued more restrictive rules for these medical laboratory tests on May 4 Last month, Roche Group CEO Severin Schwan characterized some COVID-19 antibody tests as a...